CD8A and ovarian carcinoma: Abemaciclib enhanced the chemotaxis of B cells and CD8+ T cells via a series of chemokines, including IL2, IFN-γ, CCL5, CXCL9, CXCL10, CXCL13, and CD40LG in a murine ovarian cancer model [44].